Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys 708 Shares of Doximity, Inc. (NASDAQ:DOCS)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 2.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 28,299 shares of the company’s stock after acquiring an additional 708 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Doximity were worth $1,511,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. FMR LLC increased its stake in Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the last quarter. Lord Abbett & CO. LLC acquired a new stake in shares of Doximity in the 3rd quarter valued at $29,453,000. Wilmington Savings Fund Society FSB bought a new position in shares of Doximity in the 3rd quarter valued at $24,691,000. Geode Capital Management LLC raised its holdings in shares of Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after buying an additional 472,565 shares in the last quarter. Finally, Retirement Systems of Alabama lifted its position in shares of Doximity by 254.3% during the 3rd quarter. Retirement Systems of Alabama now owns 534,256 shares of the company’s stock worth $23,278,000 after buying an additional 383,480 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DOCS shares. Raymond James reiterated an “outperform” rating and issued a $83.00 target price (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $60.00 to $90.00 in a report on Friday, February 7th. Stephens initiated coverage on shares of Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Mizuho raised their target price on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Finally, The Goldman Sachs Group upped their price target on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Doximity currently has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Activity

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 37.40% of the stock is owned by company insiders.

Doximity Stock Down 0.5 %

DOCS stock opened at $66.00 on Wednesday. The firm has a market cap of $12.32 billion, a price-to-earnings ratio of 66.00, a PEG ratio of 4.10 and a beta of 1.34. The company’s fifty day simple moving average is $65.07 and its 200 day simple moving average is $54.06. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.